Abstract
N-nitrosodimethylamine (NDMA), a probable human carcinogen, was recently detected in ranitidine products,1 prompting widespread regulatory recalls.2 Ranitidine is a histamine2-receptor antagonist that inhibits gastric acid secretion and bears a molecular structure that putatively supports NDMA production under suitable reactive and storage conditions.3 We sought to further characterize conditions of NDMA production under simulated physiologic gastric states.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
